Results

Total Results: 6,078 records

Showing results for "disorders".

  1. cdsic.ahrq.gov/sites/default/files/2023-09/SMD%20PC%20CDS%20Performance%20Measurement%20Inventory%20User%20Guide_FINAL_9.19.23.pdf
    January 01, 2023 - Scaling, Measurement, and Dissemination Workgroup: Scaling, Measurement, and Dissemination Workgroup: PC CDS Performance Measurement Inventory User Guide Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No: 75Q80120D00018 Prepared by: Prashil…
  2. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Making Healthcare Safer Practices: 16. Venous Thromboembolism Venous Thromboembolism 16-1 16. Venous Thromboembolism Eleanor Fitall, M.P.H., and Kendall K. Hall, M.D., M.S. Introduction Background Venous thromboembolism (VTE) is a disorder that includes deep vein thrombosis (DVT) and pulmonary embolism (PE). …
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_disposition-comments.pdf
    November 06, 2012 - Physical Therapy for Knee Pain Secondary to Osteoarthritis Disposition of Comment Report Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1285 Published Online: November 6, 2012 Comparative Effectiveness Research Review Disposition of Co…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2320 Published Online: October 12, 2016 Evidence Report/Technology Assessment Disposition of Comments Report R…
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - Defining an Optimal Format for Presenting Research Needs Methods Future Research Needs Report Number 3 Defining an Optimal Format for Presenting Research Needs Methods Future Research Needs Report Number 3 Defining an Optimal Format for Presenting Research Needs Pre…
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials Methods Research Report Creating Efficiencies in the Extraction of Data From Randomized Trials: A Prospective Evaluation of a Machine Learning and Text Mining Tool Methods Research Report Creating Efficie…
  7. www.ahrq.gov/sites/default/files/wysiwyg/topics/dxsafety-pediatric-safety.pdf
    September 01, 2023 - Pediatric Diagnostic Safety: State of the Science and Future Directions Issue Brief 14 Pediatric Diagnostic Safety: State of the Science and Future Directions PATIENT SAFETY e This page intentionally left blank. e Issue Brief 14 Pediatric Diagnostic Safety: State of the Science and Future Directions …
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
    June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They shou…
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
    October 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Coronary Heart Disease: Screening Using Non-Traditional Risk Factors October 15, 2009 Recommendations made by the USPSTF are independent of …
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - Gastrointestinal disorders were the most common adverse events (AEs) for liraglutide, but were transient
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - BMC Cardiovascular Disorders 10 (#date#) 7 Schaer BA, Schneider C, Jick SS, et al.. 2010.
  12. hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2015.jsp
    January 01, 2015 - large sample size, which allows for analysis across hospital types and the study of relatively uncommon disorders
  13. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - in the long term and does not have serious adverse effects, e.g., valvulopathy, neuropsychiatric disorders
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
    June 17, 2014 - Chronic childhood disorders: prevalence and impact. Pediatr Clin North Am. 1984 Feb;31(1):3-18.
  15. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - they would be reluctant to offer this therapy because it could contribute to or exacerbate eating disorders
  16. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - in the long term and does not have serious adverse effects, (e.g., valvulopathy, neuropsychiatric disorders
  17. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/qdr2015-ptschartbook.pdf
    March 04, 2016 - Antipsychotic medication use is associated with increased risks of adverse events such as movement disorders
  18. hcup-us.ahrq.gov/HCUP_Overview/HCUP_Overview/index508.jsp
    October 01, 2022 - The NEDS' large sample size enables analyses of relatively uncommon disorders and procedures and special
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
    February 25, 2014 - No deaths, malignancies, demyelinating disorders, optic neuritis, seizures, or new cases of autoimmune
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
    May 16, 2013 - regularity index; LVEDD=left ventricular/diastolic diameter; RECORDAF=Registry on Cardiac Rhythm Disorders